by
DeRoyal News | Jun 06, 2022
The FIRST-EVER in the U.S. to implement the A-View® Endotracheal Balloon Catheter in a cardiothoracic surgery by the team at The University of Tennessee Medical Center (Knoxville, TN).
Congratulations to the team at The University of Tennessee Medical Center on being the first in the U.S. to implement the A-View® Endotracheal Balloon Catheter in a cardiothoracic surgery.

(from left to right) Nick Harper, RCIS, Sr. Acute Care Product Manager for DeRoyal Industries, Inc., George Brandon, M.D., Ph.D, A-View® device co-inventor, Tommy Christianson, M.D., Arno Nierich, M.D., Ph.D, A-View®balloon inventor & Blake Moore, M.D.
A-View® Endotracheal Balloon Catheter
The A-View® balloon provides complete visualization of the distal ascending aorta during TEE, thus eliminating the 'blind spot'. This is accomplished by filling the air-void within the trachea with a saline-filled balloon, allowing for a complete diagnosis of dangerous plaques at risk for potential dislodgement prior to CPB cannulation and aortic cross clamping. The A-View® balloon has been proven to reduce the risk of periprocedural stroke by 30%*.
* Study can be found on A-View page.
A very special thanks to Blake Moore, M.D. and Tommy Christianson, M.D. on their willingness to adopt the A-View® balloon into their daily practice, ensuring better patient outcomes during cardiac-related surgeries.